- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 263/56 - Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
Patent holdings for IPC class C07D 263/56
Total number of patents in this class: 307
10-year publication summary
17
|
15
|
26
|
18
|
16
|
15
|
14
|
21
|
17
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Janssen Pharmaceutica N.V. | 3612 |
7 |
Genentech, Inc. | 3869 |
6 |
Theravance Biopharma R&D IP, LLC | 517 |
6 |
F. Hoffmann-La Roche AG | 7942 |
5 |
FUJIFILM Corporation | 28805 |
5 |
CHDI Foundation, Inc. | 108 |
5 |
Shionogi & Co., Ltd. | 889 |
5 |
Biosplice Therapeutics, Inc. | 166 |
5 |
Hoffmann-La Roche Inc. | 3267 |
4 |
BASF SE | 20432 |
4 |
Bayer Cropscience AG | 2138 |
4 |
The Board of Trustees of the University of Illinois | 2666 |
4 |
Takeda Pharmaceutical Company Limited | 2943 |
4 |
Nippon Shinyaku Co., Ltd. | 322 |
4 |
Taisho Pharmaceutical Co., Ltd. | 862 |
4 |
Toyama Chemical Co., Ltd. | 108 |
4 |
Wyeth | 496 |
4 |
Recurium IP Holdings, LLC | 148 |
4 |
Novartis AG | 11254 |
3 |
Sumitomo Chemical Company, Limited | 8988 |
3 |
Other owners | 217 |